{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:04:07Z","timestamp":1794917047240,"version":"4.9.1"},"reference-count":62,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T00:00:00Z","timestamp":1234742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Despite its well\u2010known association with IgE\u2010mediated allergy, IgG4 antibodies still have several poorly understood characteristics. IgG4 is a very dynamic antibody: the antibody is involved in a continuous process of half\u2010molecules (i.e. a heavy and attached light\u2010chain) exchange. This process, also referred to as \u2018Fab\u2010arm exchange\u2019, results usually in asymmetric antibodies with two different antigen\u2010combining sites. While these antibodies are hetero\u2010 bivalent, they will behave as monovalent antibodies in most situations. Another aspect of IgG4, still poorly understood, is its tendency to mimic IgG rheumatoid factor (RF) activity by interacting with IgG on a solid support. In contrast to conventional RF, which binds via its variable domains, the activity of IgG4 is located in its constant domains. This is potentially a source of false positives in IgG4 antibody assay results. Because regulation of IgG4 production is dependent on help by T\u2010helper type 2 (Th2) cells, the IgG4 response is largely restricted to non\u2010microbial antigens. This Th2\u2010dependency associates the IgG4 and IgE responses. Another typical feature in the immune regulation of IgG4 is its tendency to appear only after prolonged immunization. In the context of IgE\u2010mediated allergy, the appearance of IgG4 antibodies is usually associated with a decrease in symptoms. This is likely to be due, at least in part, to an allergen\u2010blocking effect at the mast cell level and\/or at the level of the antigen\u2010presenting cell (preventing IgE\u2010facilitated activation of T cells). In addition, the favourable association reflects the enhanced production of IL\u201010 and other anti\u2010inflammatory cytokines, which drive the production of IgG4. While in general, IgG4 is being associated with non\u2010activating characteristics, in some situations IgG4 antibodies have an association with pathology. Two striking examples are pemphigoid diseases and sclerosing diseases such as autoimmune pancreatitis. The mechanistic basis for the association of IgG4 with these diseases is still enigmatic. However, the association with sclerosing diseases may reflect an excessive production of anti\u2010inflammatory cytokines triggering an overwhelming expansion of IgG4\u2010producing plasma cells. The bottom line for allergy diagnosis: IgG4 by itself is unlikely to be a cause of allergic symptoms. In general, the presence of allergen\u2010specific IgG4 indicates that anti\u2010inflammatory, tolerance\u2010inducing mechanisms have been activated. The existence of the IgG4 subclass, its up\u2010regulation by anti\u2010inflammatory factors and its own anti\u2010inflammatory characteristics may help the immune system to dampen inappropriate inflammatory reactions.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2009.03207.x","type":"journal-article","created":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T06:18:23Z","timestamp":1234765103000},"page":"469-477","source":"Crossref","is-referenced-by-count":706,"title":["Immunoglobulin G4: an odd antibody"],"prefix":"10.1111","volume":"39","author":[{"given":"R. C.","family":"Aalberse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. O.","family":"Stapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schuurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Rispens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,12]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1976.tb01901.x"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000231566"},{"key":"e_1_2_10_4_2","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.4049\/jimmunol.137.11.3566","article-title":"Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency","volume":"137","author":"Van der Zee JS","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2810317"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(93)90432-B"},{"key":"e_1_2_10_7_2","first-page":"1095","article-title":"Mouse\/human chimeric IgG1 and IgG4 antibodies directed to the house dust mite allergen Der p 2","volume":"27","author":"Schuurman J","year":"1997","journal-title":"use in quantification of allergen specific IgG"},{"key":"e_1_2_10_8_2","first-page":"693","article-title":"Normal human immunoglobulin G4 is bispecific","volume":"97","author":"Schuurman J","year":"1999","journal-title":"it has two different antigen-combining sites"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0019-2805.2001.01341.x"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1144603"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02883.x"},{"key":"e_1_2_10_12_2","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.155.10.5057","article-title":"Localization of an Fc\u2010binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis","volume":"155","author":"Zack DJ","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3730"},{"key":"e_1_2_10_14_2","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.4049\/jimmunol.151.9.4528","article-title":"Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL\u20104 and hydrocortisone","volume":"151","author":"Jabara HH","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000023918"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000024099"},{"key":"e_1_2_10_17_2","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4049\/jimmunol.151.3.1280","article-title":"IL\u201010 and viral IL\u201010 prevent IL\u20104\u2010induced IgE synthesis by inhibiting the accessory cell function of monocytes","volume":"151","author":"Punnonen J","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01774.x"},{"key":"e_1_2_10_19_2","first-page":"4718","article-title":"T regulatory\u20101 cells induce IgG4 production by B cells","volume":"174","author":"Satoguina JS","year":"2005","journal-title":"role of IL-10"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2005.01.001"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.3.1767"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00631.x"},{"key":"e_1_2_10_23_2","first-page":"752","article-title":"Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen","volume":"357","author":"Platts\u2010Mills T","year":"2001","journal-title":"a population-based cross-sectional study"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000091169"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02331.x"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106318"},{"key":"e_1_2_10_27_2","first-page":"738","article-title":"Healthy immune response to allergens","volume":"18","author":"Akdis M.","year":"2006","journal-title":"T regulatory cells and more"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(01)01449-6"},{"key":"e_1_2_10_29_2","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.4049\/jimmunol.122.6.2218","article-title":"Local production of IgG, IgA and IgE antibodies in grass pollen hay fever","volume":"122","author":"Platts\u2010Mills TA.","year":"1979","journal-title":"J Immunol"},{"key":"e_1_2_10_30_2","first-page":"126","article-title":"Measurement of IgG, IgA and IgE antibodies to Dermatophagoides pteronyssinus by antigen\u2010binding assay, using a partially purified fraction of mite extract (F4P1)","volume":"34","author":"Chapman MD","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02697369"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000090277"},{"key":"e_1_2_10_33_2","first-page":"2250","article-title":"Human immunoglobulin class and IgG subclass regulation","volume":"23","author":"Kotowicz K","year":"1993","journal-title":"dual action of interleukin-4"},{"key":"e_1_2_10_34_2","first-page":"2318","article-title":"IL\u20104 plus CD40 monoclonal antibody induces human B cells gamma subclass\u2010specific isotype switch","volume":"155","author":"Fujieda S","year":"1995","journal-title":"switching to gamma 1, gamma 3, and gamma 4, but not gamma 2"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.7.4529"},{"key":"e_1_2_10_36_2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4\u2010restricted response","volume":"130","author":"Aalberse RC","year":"1983","journal-title":"J Immunol"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1991.tb00809.x"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02749.x"},{"key":"e_1_2_10_39_2","first-page":"2731","article-title":"Control of allergic reactivity in human filariasis","volume":"148","author":"Hussain R","year":"1992","journal-title":"predominant localization of blocking antibody to the IgG4 subclass"},{"key":"e_1_2_10_40_2","first-page":"372","article-title":"Th2 responses without atopy","volume":"22","author":"Yazdanbakhsh M","year":"2001","journal-title":"immunoregulation in chronic helminth infections and reduced allergic disease"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/217174a0"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613257"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07232.x"},{"issue":"2","key":"e_1_2_10_44_2","first-page":"198","article-title":"Human antichimeric antibodies to infliximab and infusion\u2010related allergic reactions in patients with rheumatoid arthritis","author":"Wouters D","year":"2007","journal-title":"Allergy Clin Immunol Int"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1159\/000236090"},{"key":"e_1_2_10_46_2","first-page":"793","article-title":"Testing for IgG4 against foods is not recommended as a diagnostic tool","volume":"63","author":"Stapel SO","year":"2008","journal-title":"EAACI task force report"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.3252"},{"key":"e_1_2_10_48_2","first-page":"1","article-title":"Effects of passive antibody in bee venom anaphylaxis","volume":"142","author":"Lessof MH","year":"1978","journal-title":"Johns Hopkins Med J"},{"key":"e_1_2_10_49_2","first-page":"289","volume-title":"Clinical reviews in allergy","author":"Aalberse RC","year":"1983"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0734-0"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2005.00367.x"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198906013202206"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.03.006"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00081.x"},{"key":"e_1_2_10_55_2","first-page":"23","article-title":"Hyper\u2010IgG4 disease","volume":"4","author":"Neild GH","year":"2006","journal-title":"report and characterisation of a new disease"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1159\/000232784"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1159\/000233000"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1982.tb01643.x"},{"key":"e_1_2_10_59_2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.160.4.1647","article-title":"Fc epsilon receptor I\u2010associated lyn\u2010dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation","volume":"160","author":"Malbec O","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_10_60_2","first-page":"404","article-title":"Complementation of Der P 2\u2010induced histamine release from human basophils sensitized with monoclonal IgE","volume":"101","author":"Schuurman J","year":"1998","journal-title":"not only by IgE, but also by IgG antibodies directed to a nonoverlapping epitope of Der p 2"},{"key":"e_1_2_10_61_2","first-page":"440","article-title":"IgE","volume":"11","author":"Mudde GC","year":"1990","journal-title":"an immunoglobulin specialized in antigen capture"},{"key":"e_1_2_10_62_2","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.4049\/jimmunol.150.8.3643","article-title":"Serum\u2010IgE\u2010facilitated allergen presentation in atopic disease","volume":"150","author":"Van der Heijden FL","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_10_63_2","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.163.5.2944","article-title":"Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum\u2010IgE\u2010facilitated allergen presentation","volume":"163","author":"Van Neerven RJ","year":"1999","journal-title":"J Immunol"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2009.03207.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2009.03207.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T18:14:42Z","timestamp":1695924882000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2009.03207.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,12]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1365-2222.2009.03207.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2009.03207.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,12]]}}}